Imidazoline Receptors

Imidazoline binding sites were originally classified into I1 sites (labeled by clonidine) and I2 sites (labeled by idazoxan). I2 sites have been further classified into I2A (amiloride-sensitive) and I2B (amiloride-insensitive). A putative I3 has been described which enhances insulin secretion. Imidazoline receptors are orphan proteins and their biological function has primarily been established by binding of selective ligands, although their protein identity has yet to be determined.

Targets

Imidazoline Receptor Target Files

I1 Receptors (I1)

I2 Receptors (I2)

Related Targets

Adrenergic α2 Receptors (α2A, α2B, α2C)

General Imidazolines

Imidazoline receptors have a physiological role in the central regulation of blood pressure. Activation of I1 receptors decreases sympathetic tone via a central mechanism, which has a hypotensive effect and reduces plasma catecholamine levels. In contrast, I2-mediated monoamine oxidase inhibition has a hypertensive effect and increases plasma catecholamine levels.

Receptor Data

Properties of Imidazoline Receptors

ReceptorI1I2I3
LocationLateral reticular nucleus, locus ceruleus, kidney, platelets, pancreasInterpeduncular and arcuate nuclei, pineal gland, liver, kidney, heart, striated muscle, MAOPancreatic β cells
Transduction Mechanism↑ Diacylglycerol and arachidonic acidUnknownUnknown
Key Selective LigandsAGN 192403 (1072)
Clonidine (0690)
Rilmenidine (0790)

2-BFI (0348)
KU14R (1131)
Putative Endogenous LigandsAgmatine, Harmane